Mesoblast Limited (ASX:MSB)

Mesoblast Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-94.37	-102.14	-87.96	-81.89	-91.35	-98.81
Depreciation & Amortization	8.63	6.4	4.67	4.11	4.38	4.26
Stock-Based Compensation	16.02	22.09	5.87	3.66	5.54	12.51
Other Operating Activities	30.56	26.74	31.59	13.33	10.78	-10.29
Change in Accounts Receivable	-41.02	5.02	-15.47	-0.12	0.14	-1.74
Change in Inventory	1.41	0.83	-	-	-	-
Change in Accounts Payable	20.8	11.78	-12.38	-0.4	4.78	-5.06
Change in Other Net Operating Assets	-2.51	-21.94	23.72	0.43	-0.05	-1.62
Operating Cash Flow	-59.64	-49.95	-48.46	-63.27	-65.78	-100.75
Capital Expenditures	-1	-0.68	-0.27	-0.26	-0.16	-1.65
Sale (Purchase) of Intangibles	-0.11	-0.05	-0.06	-0.05	-0.08	-
Other Investing Activities	-	0.61	-	-	-	-
Investing Cash Flow	-1.11	0.12	-0.1	-0.19	-0.23	-1.65
Long-Term Debt Issued	-	-	-	-	51.92	-
Long-Term Debt Repaid	-	-9.77	-13.52	-2.66	-58.25	-2.93
Net Debt Issued (Repaid)	-5.31	-9.77	-13.52	-2.66	-6.33	-2.93
Issuance of Common Stock	170.59	166.38	65.41	88.64	0.21	106.27
Other Financing Activities	-14.81	-9.28	-11.63	-11.48	-3.75	5.2
Financing Cash Flow	150.47	147.34	40.25	74.5	-9.87	108.53
Foreign Exchange Rate Adjustments	2.23	1.09	-0.06	-0.17	-0.55	1.42
Net Cash Flow	91.95	98.59	-8.36	10.87	-76.43	7.55
Free Cash Flow	-60.64	-50.63	-48.73	-63.53	-65.94	-102.4
Free Cash Flow Margin	-92.74%	-294.42%	-825.63%	-846.99%	-645.76%	-1377.40%
Free Cash Flow Per Share	-0.05	-0.04	-0.05	-0.08	-0.10	-0.17
Cash Interest Paid	9.65	5.27	5.72	6.01	6.08	5.93
Cash Income Tax Paid	-	0	-0	-0.02	0.02	0.04
Levered Free Cash Flow	-69.44	-55.12	-27.32	-60.16	-44.27	-83.01
Unlevered Free Cash Flow	-55.47	-41.53	-14.41	-48.01	-33.7	-73.05
Change in Working Capital	-20.48	-3.04	-2.63	-2.47	4.87	-8.42

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.